These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7010994)

  • 1. Interaction of minoxidil and captopril in the treatment of refractory hypertension.
    Matson JR; Norby LH; Robillard JE
    Am J Dis Child; 1981 Mar; 135(3):256-8. PubMed ID: 7010994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses.
    Baer L; Radichevich I; Williams GS
    J Cardiovasc Pharmacol; 1980; 2 Suppl 2():S206-16. PubMed ID: 6156357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril combined with minoxidil, beta-blocker and furosemide in the treatment of refractory hypertension.
    Seedat YK; Rawat R
    Eur J Clin Pharmacol; 1983; 25(1):9-11. PubMed ID: 6137387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of refractory hypertension with combined minoxidil and captopril in low doses].
    Palatini P; Pessina AC; Sperti G; Fortunato V; Gava R; Dal Palù C
    G Ital Cardiol; 1984 Jun; 14(6):401-6. PubMed ID: 6148288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril-induced metabolic acidosis with hyperkalemia.
    Sakemi T; Ohchi N; Sanai T; Rikitake O; Maeda T
    Am J Nephrol; 1988; 8(3):245-8. PubMed ID: 3071139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril in mild and severe hypertension.
    Walter NM; Whitworth JA; Kincaid-Smith P
    Clin Exp Pharmacol Physiol; 1980; 7(5):477-80. PubMed ID: 7004679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of angiotensin converting enzyme inhibitor captopril and peripheral vasodilator minoxidil in the treatment of patients with stable and malignant arterial hypertension].
    Arabidze GG; Leshchinskiĭ PM; Lordkipanidze NL; Kutsenko AI; Masenko VP
    Kardiologiia; 1983 Dec; 23(12):24-8. PubMed ID: 6321845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
    MacGregor GA; Markandu ND; Banks RA; Bayliss J; Roulston JE; Jones JC
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):693-6. PubMed ID: 6802291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer antihypertensive agents.
    Kaplan NM
    Postgrad Med; 1983 Jan; 73(1):213-5, 219-22. PubMed ID: 6336840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperkalemia resulting from captopril administration.
    Warren SE; O'Connor DT
    JAMA; 1980 Dec; 244(22):2551-2. PubMed ID: 7001073
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
    Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
    Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
    [No Abstract]   [Full Text] [Related]  

  • 12. Captopril and propranolol in mild and moderate essential hypertension: preliminary report.
    Friedlander DH
    N Z Med J; 1979 Aug; 90(642):146-9. PubMed ID: 386192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril in various forms of severe therapy-resistant hypertension.
    Studer A; Lüscher T; Siegenthaler W; Vetter W
    Klin Wochenschr; 1981 Jan; 59(2):59-67. PubMed ID: 6259406
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of antihypertensive and hormonal effects of captopril and propranolol at rest and during exercise.
    Pickering TG; Case DB; Sullivan PA; Laragh JH
    Am J Cardiol; 1982 Apr; 49(6):1566-8. PubMed ID: 7041599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossover comparison of captopril and propranolol as step 2 agents in hypertension.
    Oren A; Rotmensch HH; Vlasses PH; Riley LJ; Tadros SS; Koplin JR; Ferguson RK
    Am Heart J; 1985 Mar; 109(3 Pt 1):554-7. PubMed ID: 3883729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril in severe treatment-resistant hypertension.
    Ferguson RK; Vlasses PH; Koplin JR; Shirinian A; Burke JF; Alexander JC
    Am Heart J; 1980 May; 99(5):579-85. PubMed ID: 6989221
    [No Abstract]   [Full Text] [Related]  

  • 17. [Captopril in the treatment of essential hypertension (author's transl)].
    Lederle RM; Klaus D; Braun B
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1307-12. PubMed ID: 6257467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of single dose administration of angiotension covering enzyme inhibitor (captopril) on blood pressure, plasma renin activity and plasma aldosterone in patients with essential hypertension. A proposal for the captopril test.
    Kodama K; Morotomi Y; Kida O; Higa T; Someya N; Kondo K; Tanaka K
    Nihon Jinzo Gakkai Shi; 1984 Sep; 26(9):1243-9. PubMed ID: 6392644
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful acute and long-term treatment of renin-induced hypertension in two infants with captopril.
    Rosendahl W; Hayduk K
    Eur J Pediatr; 1980 Dec; 135(2):161-4. PubMed ID: 7004877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hypotensive and renin-stimulating actions of captopril before and during treatment with a beta-blocking drug.
    Leonetti G; Biachini C; Terzoli L; Gradnik R; Tusa M; Bramati E; Zanchetti A
    Am J Cardiol; 1982 Apr; 49(6):1564-5. PubMed ID: 6280485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.